Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Selver, Isik"'
Autor:
Seda Kahraman, Serdar Karakaya, Muhammed Ali Kaplan, Sema Sezgin Goksu, Akin Ozturk, Zehra Sucuoglu Isleyen, Jamshid Hamdard, Sedat Yildirim, Tolga Dogan, Selver Isik, Abdussamet Celebi, Burcu Belen Gulbagci, Nail Paksoy, Mutlu Dogan, Haci Mehmet Turk, Ahmet Bilici, Ali Murat Tatli, Sinem Akbas, Nedim Turan, Ilhan Hacibekiroglu, Gamze Gokoz Dogu, Adnan Aydiner, Ahmet Taner Sumbul, Serap Akyurek, Merih Yalciner, Ahmet Demirkazik, Pinar Gursoy, Musa Baris Aykan, Elif Sahin, İbrahim Karadag, Osman Kostek, Muhammed Muhiddin Er, Mehmet Artaç, Yakup Duzkopru, Dincer Aydin, Deniz Isik, Yusuf Karakas, Saadettin Kilickap, Cihan Erol, Bilgin Demir, Burak Civelek, Yakup Ergun, Muhammed Bulent Akinci, Izzet Dogan, Nuri Karadurmus, Perran Fulden Yumuk, Mehmet Ali Nahit Sendur
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract Central nervous system (CNS) metastases can be seen at a rate of 30% in advanced stages for patients with non-small cell lung cancer (NSCLC). Growing evidence indicates the predictive roles of driver gene mutations in the development of brai
Externí odkaz:
https://doaj.org/article/dfd4fc84465f4b4985707fa241e217b7
Autor:
Rukiye Arikan, Salih Ozguven, Tugba Akin Telli, Selver Isik, Nazım Can Demircan, Tugba Basoglu, Alper Yasar, Abdussamet Celebi, Nuh Filizoglu, Hilal Sagiroglu Ustun, Ilker Tinay, Tunc Ones, Halil Turgut Turoglu, Tanju Yusuf Erdil, Mehmet Akif Ozturk, Ozlem Ercelep, Vedat Bayoglu, Osman Kostek, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Acta Radiologica. 64:2040-2049
Background Prognostic markers in metastatic renal cell cancer (mRCC) are still insufficient. Any prognostic model objectively determines disease burden. Purpose To investigate the relationship between 18-fluorodeoxyglucose (18F-FDG) positron emission
Autor:
Tugba Akin Telli, Salih Ozguven, Ozkan Alan, Nuh Filizoglu, Mehmet Akif Ozturk, Nisanur Sariyar, Selver Isik, Rukiye Arikan, Nazim Can Demircan, Tugba Basoglu, Ilknur Alsan Cetin, Tunc Ones, Ozlem Ercelep, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Annals of Nuclear Medicine. 36:964-975
Objective We aimed to evaluate whether baseline Ga-68-PSMA PET/CT-derived whole-body volumetric parameters could be used as predictive biomarkers for survival in metastatic castration-resistant prostate cancer (mCRPC) patients receiving first-line tr
Autor:
Tugba Akin Telli, Ozkan Alan, Nazim Can Demircan, Nisanur Sariyar, Rukiye Arikan, Tugba Basoglu, Alper Yasar, Abdussamet Celebi, Selver Isik, Omer Sofulu, Bulent Erol, Huseyin Kemal Turkoz, Zerrin Ozgen, Ozlem Ercelep, Faysal Dane, Perran Fulden Yumuk
Publikováno v:
Revue de Chirurgie Orthopédique et Traumatologique. 109:463-464
Autor:
Tugba Akin, Telli, Ozkan, Alan, Nazim Can, Demircan, Nisanur, Sariyar, Rukiye, Arikan, Tugba, Basoglu, Alper, Yasar, Abdussamet, Celebi, Selver, Isik, Omer, Sofulu, Bulent, Erol, Huseyin Kemal, Turkoz, Zerrin, Ozgen, Ozlem, Ercelep, Faysal, Dane, Perran Fulden, Yumuk
Publikováno v:
Orthopaedics & Traumatology: Surgery & Research. 109:103491
Advanced age and presence of comorbidities affect prognosis and treatment decisions in patients with soft tissue sarcoma (STS). However, coeffect of age and comorbidities is still unknown. We aimed to investigate prognostic value of age-adjusted Char
Autor:
Özgür Cem Müsri, Selver Isik, Gokhan Tazegul, Ahmet Erkan Bilici, Melek Karakurt Eryilmaz, Fatma Yalçin Müsri, Muhammed Ali Kaplan
Publikováno v:
Volume: 46, Issue: 2 203-208
Uludağ Üniversitesi Tıp Fakültesi Dergisi
Uludağ Üniversitesi Tıp Fakültesi Dergisi
Herein, we aimed to evaluate the prognostic significance of the ratio of metastatic lymph nodes to the total number of removed lymph nodes (LNR) in Stage 1-3 operated gastric carcinoma (GC). A total of 233 patients with stage 1-3 GC operated between
Autor:
Tugba Akin, Telli, Salih, Ozguven, Ozkan, Alan, Nuh, Filizoglu, Mehmet Akif, Ozturk, Nisanur, Sariyar, Selver, Isik, Rukiye, Arikan, Nazim Can, Demircan, Tugba, Basoglu, Ilknur Alsan, Cetin, Tunc, Ones, Ozlem, Ercelep, Faysal, Dane, Perran Fulden, Yumuk
Publikováno v:
Annals of nuclear medicine. 36(11)
We aimed to evaluate whether baselineThis retrospective study included 54 mCRPC patients, who underwent baselineDocetaxel and abiraterone/enzalutamide were administered to 32 and 22 patients in the first-line setting, respectively. wbPSMA-TV (rho = 0
Autor:
Serdar Arici, Ferdi Aksaray, Nurgul Yasar, Cumhur Demir, Sener Cihan, Caglayan Geredeli, Abdullah Sakin, Selver Isik
Publikováno v:
Asian Pacific Journal of Cancer Prevention : APJCP
Background: The aim of this study was to investigate the effect of platelet parameters before concurrent chemoradiotherapy (CCRT) on survival of patients with limited disease small cell lung cancer (LD-SCLC). Methods: This study consisted of patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71f262ac23a3ce75659558abbab77042
https://avesis.yyu.edu.tr/publication/details/c2d610e9-0aef-4e21-b593-29aafff7360f/oai
https://avesis.yyu.edu.tr/publication/details/c2d610e9-0aef-4e21-b593-29aafff7360f/oai
Publikováno v:
Eurasian Journal of Medical Investigation.
Objectives: Arterial and venous thrombotic events are more commonly observed in patients with myeloproliferativediseases (MPDs). Arterial and venous thromboses are significant causes of mortality and morbidity in Philadelphia (Ph)chromosome-negative